The red up/down arrow next to a specific parameter indicates a relative increase or decrease in that parameter when the combination therapy is compared with low-dose lovastatin alone. Credit must be ...
Mixed hyperlipidemia is a highly prevalent disorder characterized ... Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA ...
Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia - ARO-DIMER-PA is designed to selectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback